Literature DB >> 31686299

Effect of the Antimicrobial Peptide LL-37 on Gene Expression of Chemokines and 29 Toll-like Receptor-Associated Proteins in Human Gingival Fibroblasts Under Stimulation with Porphyromonas gingivalis Lipopolysaccharide.

Megumi Inomata1, Toshi Horie2, Takeshi Into3.   

Abstract

The antimicrobial peptide LL-37 neutralizes the biological activity of lipopolysaccharide (LPS), while it upregulates the expression of several immune-related genes. We investigated the effect of LL-37 on gene regulation of human gingival fibroblasts (HGFs), stimulated with or without Porphyromonas gingivalis-derived LPS, a ligand for Toll-like receptor (TLR). LL-37 was non-toxic to HGFs up to a concentration of 10 μg/ml. P. gingivalis LPS upregulated the expression of IL8, CXCL10, and CCL2, whereas LL-37 reduced this upregulation. In absence of LPS, LL-37 itself upregulated the expression of IL8 and CCL2. LL-37 increased the expression of P2X7, which was constitutively expressed in HGFs. The P2X7 antagonist A-438079 suppressed the cytotoxicity and upregulatory effect of LL-37 on chemokine response, but not its downregulatory effect on P. gingivalis LPS-induced chemokine response. Whether LL-37 alters the expression of 29 genes that encode TLR-associated proteins, including TLRs, co-receptors, signaling molecules, and negative regulators, in HGFs, under stimulation with LPS, was examined. Among TLRs, P. gingivalis LPS upregulated the level of TLR4, whereas LL-37 reduced it. In co-receptors, LL-37 downregulated the level of CD14. Among signaling molecules, LL-37 augmented the LPS-upregulated expression of IRAK1. Similar effects were observed in the specific negative regulators TNFAIP3, RNF216, TOLLIP, and SIGIRR. Our results suggest that LL-37 exerts cytotoxicity and upregulation of chemokine response via the P2X7 receptor, while it induces downregulation of P. gingivalis LPS-induced chemokine response through alteration in the expression of 7 specific TLR-associated genes: downregulation of TLR4 and CD14 and upregulation of IRAK1, TNFAIP3, RNF216, TOLLIP, and SIGIRR.

Entities:  

Keywords:  Human gingival fibroblasts; LL-37; Porphyromonas gingivalis lipopolysaccharide; Toll-like receptor

Mesh:

Substances:

Year:  2020        PMID: 31686299     DOI: 10.1007/s12602-019-09600-2

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  46 in total

1.  IRAK-M is a negative regulator of Toll-like receptor signaling.

Authors:  Koichi Kobayashi; Lorraine D Hernandez; Jorge E Galán; Charles A Janeway; Ruslan Medzhitov; Richard A Flavell
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

2.  Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors.

Authors:  Tsung-Hsien Chuang; Richard J Ulevitch
Journal:  Nat Immunol       Date:  2004-04-25       Impact factor: 25.606

Review 3.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

4.  The antimicrobial peptide LL-37 enhances IL-8 release by human airway smooth muscle cells.

Authors:  Suzanne Zuyderduyn; Dennis K Ninaber; Pieter S Hiemstra; Klaus F Rabe
Journal:  J Allergy Clin Immunol       Date:  2006-06       Impact factor: 10.793

5.  Different effects of P. gingivalis LPS and E. coli LPS on the expression of interleukin-6 in human gingival fibroblasts.

Authors:  Oleh Andrukhov; Sandra Ertlschweiger; Andreas Moritz; Hans-Peter Bantleon; Xiaohui Rausch-Fan
Journal:  Acta Odontol Scand       Date:  2013-11-21       Impact factor: 2.331

6.  Lipopolysaccharide preparation extracted from Porphyromonas gingivalis lipoprotein-deficient mutant shows a marked decrease in toll-like receptor 2-mediated signaling.

Authors:  Yasuyuki Asai; Masahito Hashimoto; Hansel M Fletcher; Kensuke Miyake; Shizuo Akira; Tomohiko Ogawa
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

7.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.

Authors:  David L Boone; Emre E Turer; Eric G Lee; Regina-Celeste Ahmad; Matthew T Wheeler; Colleen Tsui; Paula Hurley; Marcia Chien; Sophia Chai; Osamu Hitotsumatsu; Elizabeth McNally; Cecile Pickart; Averil Ma
Journal:  Nat Immunol       Date:  2004-08-29       Impact factor: 25.606

8.  The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner.

Authors:  Linda Tomasinsig; Cinzia Pizzirani; Barbara Skerlavaj; Patrizia Pellegatti; Sara Gulinelli; Alessandro Tossi; Francesco Di Virgilio; Margherita Zanetti
Journal:  J Biol Chem       Date:  2008-09-02       Impact factor: 5.157

Review 9.  Porphyromonas gingivalis lipopolysaccharide signaling in gingival fibroblasts-CD14 and Toll-like receptors.

Authors:  P-L Wang; K Ohura
Journal:  Crit Rev Oral Biol Med       Date:  2002

10.  Tetra- and penta-acylated lipid A structures of Porphyromonas gingivalis LPS differentially activate TLR4-mediated NF-κB signal transduction cascade and immuno-inflammatory response in human gingival fibroblasts.

Authors:  Thanuja D K Herath; Richard P Darveau; Chaminda J Seneviratne; Cun-Yu Wang; Yu Wang; Lijian Jin
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

View more
  2 in total

1.  Antibacterial and Anti-Inflammatory Properties of a Novel Antimicrobial Peptide Derived from LL-37.

Authors:  Haiwei Zhuo; Xi Zhang; Maogen Li; Qian Zhang; Yonglan Wang
Journal:  Antibiotics (Basel)       Date:  2022-06-01

2.  Protective effects of the notoginsenoside R1 on acute lung injury by regulating the miR-128-2-5p/Tollip signaling pathway in rats with severe acute pancreatitis.

Authors:  Ju He; Ming-Wei Liu; Zhi-Yi Wang; Rong-Jie Shi
Journal:  Innate Immun       Date:  2022-01       Impact factor: 2.680

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.